AI assistant
Sending…
HEALTHEQUITY, INC. — Director's Dealing 2021
Feb 3, 2021
30722_dirs_2021-02-03_d7e3de58-6921-402b-b1be-45525ef2b01d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HEALTHEQUITY, INC. (HQY)
CIK: 0001428336
Period of Report: 2021-02-01
Reporting Person: Wellborn Gayle Furgurson (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-01 | Common Stock | A | 2266 | — | Acquired | 12809 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to buy) | $47.21 | 2027-08-01 | Common Stock (7736) | 7736 | Direct |
| Stock Options (right to buy) | $50.41 | 2028-02-01 | Common Stock (4339) | 4339 | Direct |
Footnotes
F1: Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The restricted stock units vest as to 1,133 shares on the date of the issuer's annual stockholder meeting held in the current fiscal year; the remainder will vest on January 31, 2022. Vested shares will be delivered to the reporting person upon vesting.
F2: The option is immediately exercisable.
More from HEALTHEQUITY, INC.
Interim / Quarterly Report
2026
May 28
Regulatory Filings
2026
May 28
Annual Report
2026
May 13
Regulatory Filings
2026
Apr 6
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Annual Report
2026
Mar 17